Pantoprazole

Synonyms: SKFSKF96022, BY-1023

Pantoprazole (SKF96022, BY-1023) is a proton pump inhibitor drug that inhibits gastric acid secretion. It works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid.

Pantoprazole  Chemical Structure

Pantoprazole Chemical Structure

CAS No. 102625-70-7

Purity & Quality Control

Batch: S210501 DMSO]76 mg/mL]false]Ethanol]76 mg/mL]false]Water]Insoluble]false Purity: 99.94%
99.94

Pantoprazole Related Products

Biological Activity

Description Pantoprazole (SKF96022, BY-1023) is a proton pump inhibitor drug that inhibits gastric acid secretion. It works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid.
Targets
(H+/K+)-ATPase [1] Proton pump [1]
In vitro
In vitro PPZ(Pantoprazole) inhibits the proliferation of tumor cells, induces apoptosis and downregulates the expression of PKM2, which contributes to the current understanding of the functional association between PPZ and PKM2(The human M2 isoform of pyruvate kinase)[2]. Ex vivo studies showed that pantoprazole inhibited TOPK activities in JB6 Cl41 cells and HCT 116 colorectal cancer cells. Moreover, knockdown of TOPK in HCT 116 cells decreased their sensitivities to pantoprazole[3].
Cell Research Cell lines SGC-7901 cells
Concentrations 5 mg/ml
Incubation Time 24 h
Method

The SGC-7901 cells are seeded in 100 µl of medium per well, at a density of 1x104/well, in 96-well plates and treated with 5 mg/ml PPZ for 24 h. The cytotoxicity of PPZ is assessed by a cell counting kit-8 assay. The cytotoxicity is expressed as the relative cell viability, using the following formula: Cell viability (%) = (OD of drug-treated sample/OD of untreated sample) x 100. The experiment is repeated 3 times.

In Vivo
In vivo i.p. injection of pantoprazole in HCT 116 colon tumor-bearing mice effectively suppresses cancer growth. The TOPK downstream signaling molecule phospho-histone H3 in tumor tissues is also decreased after pantoprazole treatment[3]. At higher infusion rates, pantoprazole is able to induce negative hemodynamic responses, in particular, in the setting of heart failure. These effects can lead to significant impairment of cardiac function[4]. Also, pantoprazole delays fracture healing by affecting both bone formation and bone remodeling[5].
Animal Research Animal Models Non-obese Diabetic/Severe Combined Immunodeficiency (NOD-SCID) mice
Dosages 100 mg/kg
Administration i.p.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04248335 Recruiting
Pediatric Obesity|NAFLD|GERD
Children''s Mercy Hospital Kansas City
July 3 2018 Phase 4
NCT02401035 Terminated
Gastroesophageal Reflux Disease
Pfizer
May 9 2017 Phase 4
NCT02274961 Unknown status
Non Erosive Reflux Disease
Ahn-Gook Pharmaceuticals Co.Ltd
October 2014 Phase 3
NCT02186652 Completed
Gastroesophageal Reflux Disease
Phillip Brian Smith|The Emmes Company LLC|Duke University
June 4 2014 Phase 1
NCT01710462 Withdrawn
Gastroesophageal Reflux Disease
Eurofarma Laboratorios S.A.
August 2013 Phase 3

Chemical Information & Solubility

Molecular Weight 383.37 Formula

C16H15F2N3O4S

CAS No. 102625-70-7 SDF Download Pantoprazole SDF
Smiles COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 76 mg/mL ( (198.24 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 76 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Pantoprazole | Pantoprazole supplier | purchase Pantoprazole | Pantoprazole cost | Pantoprazole manufacturer | order Pantoprazole | Pantoprazole distributor